|
While neuromuscular disorders are a diverse group of disorders, most are
progressive and will negatively impact function and quality of life.
Regardless of the underlying pathophysiology, the principles of assessment
of impairment and resultant potential for disability are similar. The
general principles of therapeutic exercise, functional retraining, bracing,
surgical correction of deformities, use of adaptive aids, and prevention of
secondary complications apply to all. Because of the multiple system
involvement, unpredictability and variability of progression, a model of
care that includes an interdisciplinary approach that is regularly scheduled
with standard measures for re-evaluation is best.
Introduction. Neuromuscular disorders are a grouping of conditions with
onset from birth to adulthood, slowly to very rapidly progressive, and
associated mild to severe disability. While far from an exhaustive list,
Table 1, illustrates a classification scheme and the examples of more common
disorders demonstrate the heterogeneity of this grouping. Other references
list more detailed classification systems.1- 3
| Table 1.
|
|
Neuromuscular Disorders
|
Examples
|
CNS: Brain and Spinal Cord
Upper Motor Neuron Disorders
Combined Upper & Lower Motor
Neuron Disorders
Lower Motor Neuron Disorders |
Cerebral Palsy
Primary Lateral Sclerosis
Familial Hereditary Spastic Paraplegia
ALS
Spinal (bulbospinal muscular) Atrophies
Poliomyelitis and Post-Polio Syndrome |
Peripheral Nerves
Categorized by:
- Motor and/or Sensory
- Axonal and/or Demyelinating
- Hereditary vs. Acquired
|
Charcot-Marie-Tooth Disease
(axonol motor hereditary)
Hereditary sensory neuropathies
Herpes Zoster |
|
Neuromucular Junction |
Myasthenia Gravis
Botulism |
|
Muscle |
Muscular Dystrophies
Inflammatory Myopathies |
The clinical manifestations of neuromuscular disease (NMD) can include
weakness, spasticity, atrophy and fatigue of skeletal muscle, bulbar
involvement affecting communication and swallowing, restrictive lung
disease, cardiac dysfunction, and cognitive deficits. As the conditions
progress there are secondary problems and complications that may develop
including limb contractures, spinal deformities, problems with skin
integrity, bowel and bladder difficulties, respiratory infections,
nutritional compromise, pain, and psychosocial issues. While not curable, NMD
is treatable. Despite the diversity of conditions the approach to treatment
is very much the same. This comprehensive approach to management includes:
1) drug treatments to slow or delay progression, 2) assisting the individual
to maximize daily functional activities and participation in home, work, and
social roles, and 3) minimizing physical deformity and secondary
complications. This must be done in the context of knowledgeable counseling
regarding expected effects on body structure and functioning and progression
of conditions. The care provider(s) should then evaluate the individual
physical, family, and social environment, identify quality and end-of-life
wishes to develop shared goals for a palliative and rehabilitative process.
This is done with the understanding that this is an ongoing dynamic process.
The Interdisciplinary Team. This comprehensive treatment approach is a
difficult task for a single care provider. In many cases, the major
impediment to institution of interventions is lack of awareness of existence
or availability on the part of the patient and primary care provider. In
addition, it is often not clear what the appropriate timing is for available
interventions. For these reasons an interdisciplinary approach is more
effective. This implies coordination of services among professionals with
specific expertise. An interdisciplinary team may consist of physicians
(neurology, physiatry, primary care, pulmonology, and orthopedics), physical
therapist, occupational therapist, speech therapists, social workers,
vocational counselor, and psychologists. Ideally all of the key personnel
should be available at each patient visit. However due to constraints of
reimbursement, and availability of personnel, this type of comprehensive
service may only be feasible at tertiary care medical centers in larger
urban areas often with support of the local service organization. When these
resources are not available, a reasonable alternative would be a clinic that
is scheduled at routine intervals with the patient and smaller team, such as
a neurologist, a physiatrist, and a clinic administrator. Each individual
being assigned specific responsibilities for education, referral and
communication with other care providers, and community resources. The
neurologist role is key to diagnosis, initial education regarding disease,
prognosis and treatments available, and monitoring of response. The
physiatrist role would be to assess impairment, restrictions in activity and
participation, and environmental limitations to define functional goals. The
physiatrist will refer and coordinate care with a rehabilitative team that
will include at varying times therapists, social worker, case managers,
equipment vendors, psychologists, other physician specialists, and home care
agencies. The clinic administrator has a key role in assuring follow-through
with the recommendations at the time of the clinic by communicating with
third party payers, getting appropriate authorizations for referral,
assisting with scheduling, and obtaining documentation for the patient
record.
Evaluation of the Patient with Neuromuscular Disease. While each NMD is
different with regard to presentation, course and impact on life expectancy,
all essentially involve multiple organ systems with resultant activity
limitations and disadvantage for participation in usual family, social, and
community roles. Therefore, in addition to evaluating the affect of the
disease process on the organ system, the actual impact on daily functioning
in multiple areas also needs to be directly measured. These functions
include, but are not limited to, ambulation, activities of daily living,
communication, nutritional status, community mobility, and work performance.
Table 2 illustrates use
of the World Health Organization new ICIDH-2 definitions of impairment;
activity restriction and participation restriction (formerly impairment,
disability, and handicap) based on organ systems as a scheme for evaluation
of NMD.4, 5
| Table 2. Limitation and restriction in neuromuscular disease |
|
Organ
|
Impairment
(often progressive) |
Activity
Limitation
|
Participation
Restriction
|
|
Skeletal muscle |
Decreased strength and endurance |
Decreased motor performance
Decreased mobility
Decreased UE function
Increased fatigue |
Decreased community mobility
Decreased educational opportunities
Decreased employment opportunities
Increased dependency on others |
|
Bone & Joint |
Joint contractures
Scoliosis
|
Decreased function for mobility and ADLs
Pain & Deformity
|
Decreased quality of life |
|
Lungs
|
Decreased pulmonary function
|
Decreased endurance
Increased fatigue |
|
|
Heart
|
Cardiomyopathy
Conduction defects
|
Decreased cardio-pulmonary adaptations
Decreased endurance
Increased fatigue
|
|
|
CNS
|
Decreased intellectual capacity
|
Decreased learning ability
Decreased psychosocial adjustment |
|
Regularly scheduled evaluations with defined standardized measures is the
best way to consistently and comprehensively address progression and
facilitate timely intervention. Measures of strength, spasticity, range of
motion of extremities and spine, coordination, weight; upper extremity
function and gait should be completed at each follow-up. Based on knowledge
of organ involvement for each condition, additional interview and modified
review of systems will determine use of other measures. This then guides
referrals to therapists and other medical consultants.
Organ System Involvement. Musculoskeletal. Weakness and the Role of Exercise.
It is known that physically inactive people have twice the risk of coronary
heart disease than the more active population. Presumed a result of weakness
that is common to all NMD, most individuals have a sedentary lifestyle and
for those with more slowly progressive disorders tend to be overweight. It
follows that a sedentary adult with NMD will not only have weakness from the
disease itself, but additional weakness of disuse further adding to
limitations and restrictions. On the other side of this concern is
development of overuse weakness. This is prolonged increased weakness
following strengthening exercise that result in a decline in function. There
currently is insufficient research for specific exercise guidelines for
persons with progressive NMD. This is in part due to the relatively small
numbers of individuals with each condition. Studies that have been done
often group disorders together most often based on rate of progression.
Based on these studies the following guidelines are suggested: 1) For
persons with slowly progressive disorders, the goal is to improve strength
rather than to just retard loss with the assumption that greater strength
creates more reserve to perform daily tasks and lessens fatigue. 2) A
submaximal-strengthening program is appropriate for persons with NMD, but
there is a risk of increasing weakness with maximal strengthening programs
that includes sets of high-resistance low repetition training. 3) Modest
improvements in aerobic capacity without overwork weakness or excessive
fatigue can be achieved with education and training in a low to moderate
intensity aerobic exercise program. 4) Stretching has benefits to maintain
range of motion to enhance and preserve function and should be incorporated
early and included in every exercise prescription.5
For persons with rapidly progressive disorder, there are no studies
regarding the effectiveness of strengthening in this population due to
variability in presentation and difficulty in interpreting results in the
face of progressive weakness due to the underlying disease. Submaximal
strengthening programs may delay strength loss. In more advanced weakness,
simply completing daily activities may result in near maximal use of
strength reserves and one must consider the effects of an exercise program
on the ability to participate in a full day without excessive fatigue.
Limb Contractures. In many of the progressive NMD conditions, limb
contractures are common leading to greater disability, problems with
mobility, activities of daily living, and often pain. Weakness combined with
spasticity and inability to achieve active joint mobilization is the most
common cause of contractures. In some NMDs, contractures are due to
intrinsic muscle tissue alterations, such intrinsic loss of muscle fibers,
necrosis of muscle fibers, and fibrosis. Collagen and fatty tissue replace
functioning muscle and when combined with positioning in a shortened resting
muscle length results in contracture. Individuals with conditions that have
a more gradual progressive course and are associated with more fibrosis and
fatty infiltration will have more problems with contractures. Those with
rapidly progressive conditions and neurogenic cause of muscle weakness tend
to develop less severe contractures.7
Evaluation of cause and prevention of contracture involves the understanding
of functional anatomy of muscles and joints, effects of muscle imbalances,
compensatory measures developed to stabilize joints and maintain upright
stance, and the effect of loss of weight bearing and static positioning.
Joint range of motion should be monitored regularly with objective
goniometric measurement. Management involves early referral and education
regarding the importance of passive range of motion, and splinting while
contractures are still mild. As weakness progresses and mobility declines
additional measures such as prescribed standing and walking activities,
positioning lower extremities in extension, and orthoses to facilitate
function are added. Once contractures become fixed, they respond poorly to
stretching programs and orthopedic surgical management may help to regain
lost function or minimize the degree of limitation.
Spinal Deformities. Spinal deformity develops in several progressive NMDs.
Again, effective management requires an understanding of the age of onset
and natural history of spinal deformities in specific conditions. Spinal
deformity is more severe in conditions with childhood onset and acquired
most often in association with adolescent growth spurt. Severity also
increases with age and appears to be correlated with the length of time of
reliance on wheelchair.8 Progression of scoliosis further negatively impacts
positioning and sitting balance, causes pain, interferes with attendant
care, and exacerbates underlying restrictive pulmonary disease. While spinal orthoses are used in younger patients to provide postural support and
balanced sitting, they are not thought to prevent progression. Surgical
management with spinal arthrodesis and internal instrumentation is often
required by the second decade but undertaken with caution. A
multidisciplinary evaluation and decision making process is required due to
potential impact on cardiac, pulmonary, and physical functional abilities.
Pulmonary. Breathing problems are the leading cause of mortality in
neuromuscular disease.9 Respiratory problems and failure in NMD is most
often insidious and results from several factors including, 1) respiratory
muscle weakness and fatigue causing restrictive lung disease,
hypoventilation, and hypercarbia, 2) alteration of respiratory system
mechanics due to stiffness in lung and chest wall, airway secretions with
ineffective cough, and chest and thoracic deformities, and 3) impaired
central control of respiration most often initially presenting in
association with sleep.10 Careful history taking regarding exertional
dyspnea, orthopnea, altered breathing patterns would indicate respiratory
muscle dysfunction whereas complaints of nightmares, morning headache or
daytime drowsiness would suggest sleep-disordered breathing. These signs and
symptoms can be further assessed by pulmonary function testing and sleep
studies. Arterial blood gas screening is more appropriate in this population
rather than pulse oximetry in order to detect hypercapnia. In rapidly
progressive conditions, such as ALS, early pulmonary consultation is
warranted. A number of techniques, including several forms of mechanical
ventilation and physical aids to assist airway hygiene are available.
Identification of appropriate use should be assisted by pulmonary
consultation and based on prior discussion with the patient regarding wishes
for assisted ventilation. Other critical considerations include family and
community support systems, third party payment, and vendor contracts.
Cardiac. NMDs vary widely in their degree of cardiac involvement. In Charcot-Marie-Tooth,
which involves the lower extremities, cardiac abnormalities are rare. In ALS
cardiac involvement is most often associated with autonomic dysfunction. In
DMD, cardiac problems may include cardiomyopathy, pulmonary hypertension,
heart failure, arrhythmia, and mitral valve prolapse. This involvement may
result in significant morbidity and mortality with a 5% incidence of sudden
death.11 Knowledge of potential for involvement in each individual condition
is important to set up appropriate screening and early referral. Generally
EKG is the first test to become abnormal and regular screening in those at
risk is prudent. In conditions where cardiomyopathy is common the next step
would be to proceed with echocardiography. Documented cardiomyopathy,
arrhythmia and valvular disorders should be treated by referral to primary
physician and/or cardiologist for considerations for antiarrhythmics,
anticoagulation for prevention of embolic events, and antibiotic
prophylaxis. These cardiac conditions will also have an impact on
rehabilitation in the form of altered physical capacity for sustained
functional activities. Recommendations for restrictions and precautions
should be obtained from the cardiology consultant. Alterations in the
rehabilitation management may include earlier use of assistive devices and
power wheelchairs to reduce the workload.
Cognitive. Again the significance of cognitive problems in NMD varies from
no involvement to severe underscoring the need to understand the impact for
each condition for purposes of counseling and goal setting. Cognitive
problems appear to be quite common in Duchenne muscular dystrophy and
congenital myotonic dystrophy perhaps because they have been most studied.
The etiology of the cognitive problems is not clear. There is also
significant additional impact of chronic progressive disease on psychosocial
(eg, depression, isolation) function, educational opportunities affecting
both children and adults which may cause or aggravate apparent cognitive
problems. Referral to neuropsychology is helpful in sorting this out.
Nutritional Considerations. There are two ends of the spectrum when
evaluating nutritional status in individuals with NMD. The increasing
physical inactivity due to progressive muscle weakness and associated
changes in energy metabolism can result in excess body fat and obesity. In
this case weight management is indicated as excess weight further burdens
breathing and already weakened muscles making function more difficult. There
is little evidence of how to do this. However it would be prudent to involve
a nutritionist or dietician as part of the rehabilitation team if an
individualÕs obesity is felt to be negatively impacting function or quality
of life.
In more advanced stages or rapidly progressive NMD patients tend to lose
weight due to dysphagia and the increased time and energy to eat. When
nutritional intake is inadequate, there is associated acceleration in
breakdown of skeletal muscle. In this case, careful monitoring of weight and
nutritional laboratory parameters helps to predict when early intervention
with nutritional supplements is appropriate. Based on prior knowledge of the
patients wishes, enteral feeding with a gastric feeding tube should be
considered and instituted timely.
Timing of Rehabilitation and Adaptive Equipment. Overall management of
progressive neurologic conditions has been divided into prospective care and
expectant care.12 Prospective care involves all of the measures to maintain
health, physical function and quality of life. Expectant care includes
anticipation of complications that might be expected during the course of
the disease. Measures instituted early can help to minimize these
complications. This expectant care is facilitated by regular follow-up. Even
with this type of care it is often not clear when it is appropriate to
institute interventions particularly in the case of durable medical
equipment that may be costly and require documentation of medical necessity
for insurance benefits.
Table 3 illustrates a guided treatment approach based on assessment of
impairment. Amyotrophic Lateral Sclerosis (ALS) is presented as an example
with the course divided in phases and stages.13 ALS is variable in its
progression. The median survival is 2.5 years post diagnosis. However with
presentation of primary bulbar symptoms, the 50% survival is one year. There
are however those who have a more gradual progression with survival up to 15
to 20 years. In this model there may be overlap of the stages and phases
depending on severity of upper versus lower extremity involvement and the
severity of bulbar involvement. Once a referral is made to a therapist or
consultant, it is expected that a schedule of regular re-evaluation will be
instituted to identify treatment either in a comprehensive clinic setting or
another model of comprehensive care.
| Table 3. Treatment scheme for ALS |
| |
Disability
|
Referral
|
Treatment |
Phase 1
Stage 1
Mild weakness or clumsiness
|
ADLs independent
Ambulation independent without assist
|
PT
|
Education about nutritional principles
Institute submaximal
strengthening, aerobic and strengthening exercise
Psychological support |
Stage 2
Moderate selective weakness
|
Difficulty with ADLs requiring increased time
Ambulatory but difficulty with stairs |
OT
|
Educate about fatigue management and avoiding overuse
Provide adaptive aides for ADLs
Reinforce focused stretching for at-risk joints (eg, ankle)
Modify strengthening program to encourage strengthening of less affected muscles
Evaluate for Ankle-foot orthoses and gait aides |
Stage 3
Moderate selective weakness stretch
Easy fatigability limits sustained function
Positive respiratory symptoms
|
Moderate difficulty with ADLs.
Unable to perform some fine motor functions
Difficulty with ambulation distance
|
Pulmonary PFTs
|
Focus exercise on range of
motion, stretch
Consider hydrotherapy referral exercises
Instruction in deep
breathing
Re-evaluate need for adaptive
equipment
Home/work site evaluation
WC considerations for long distance mobility |
Phase 2
Stage 4
Severe LE weakness
Spasticity detectable
Moderate UE weakness
Shoulder pain may be present
Daytime somnolence
|
Need partial assistance with ADLs
Non-ambulatory
Able to transfer |
|
Instruct caregivers in passive ROM
Possibility isometric exercises
Modalities and medications to treat
pain
Institute anti-edema measures
Evaluate ability to propel WC |
Stage 5
Severe LE weakness
Mod-Severe UE
Concern regarding nutritional intake
Possible dysphagia for liquids
Mild to moderate dysarthria
|
More assist with ADLs
Needs assist with transfer
May have difficulty with repositioning
|
Speech-Language MBS |
Stress importance of stretching and instruct in
positioning to avoid contractures
Retrain in transfers with adaptive equipment
and/or family training
Evaluate for pressure relief in chair and bed
Re-evaluate ability to propel PWC and explore options
Consider nutritional supplements
Initiate swallow assessment and education
|
Phase 3
Severe Quadriparesis
Moderate to severe Bulbar involvement
|
Dysphagia
Severe Dysarthria
Difficulty managing secretions
Difficulty maintaining O2 saturation
Dependant in ADLs
Dependant in mobility with exception of PWC
|
|
Consideration of gastric feeding tube
Augmentative communication devices
Suction or medications to decrease salivary flow
O2 supplement and consideration of ventilatory support
Family education and support for care
Transfer devices
Hospital bed with appropriate pressure relief
Consideration of Hospice care
|
|
References
1 Brett EM, Lake BD. Neuromuscular Disorder I. Primary muscle disease and
anterior horn cell disorder. In: Brett EM, ed. Pediatric Neurology. Ed. 2.
New York, Churchill Livingston, 1991:53-115.
2. Maloney FP, Burks JS, Ringel SP, eds. Interdisciplinary rehabilitation of
multiple sclerosis and neuromuscular disorders. Philadelphia. JB Lippincott,
1985.
3. Krivickas LS. Electrodiagnosis in neuromuscular diseases.
PM&R Clinics N
Amer.1998;9(1):83-114.
4. Fowler WM, Abresch RT, Aitkens SA, et al. Impairment and disciplinary
profiles of neuromuscular diseases: Design of the protocol. Am J Phys Med Rehabil. 1995;74(2):S62-69.
5. World Health Organization: ICIDH-2 Prefinal Draft, October 2000.
6. Kilmer DD. The role of exercise in neuromuscular disease.
PM&R Clinics N
Amer. 1995;9(1):115-125.
7. McDonald CV. Limb contractures in progressive neuromuscular disease and
the role of stretching, orthotics and surgery. PM&R Clinics N Amer.
1995;9(1):187-211.
8. Lord J, Behrman B, Varzos N, et al. Acoliosis associated with Duchenne
muscular dystrophy. Arch Phys Med Rehabil.1990;71:13-17.
9. Gilroy J, Cahalan JL, Berman R, et al. Cardiac and pulmonary
complications in DuchenneÕs peripheral muscular dystrophy. Circulation.
1963;27:484-493.
10. Benditt JO. Management of pulmonary complications in neuromuscular
disease. PM&R Clinics N Amer. 1995;9(1):167-185.
11. Yanagisawa A, Miyagawa M, Yotsukura M, et al. The prevalence and
prognostic significance of arrhythmias in Duchenne type muscular dystrophy.
Am Hear J. 1992;124:1244.
12. Pease WS, Johnson EW. Rehabilitation management of diseases of the motor
unit. In: Kottke FJ, Lehmann JF, eds. Krusen's Handbook of Physical Medicine
and Rehabilitation, Ed 4. Philadelphia, WB Saunders. 1990;754-764.
13. Agre JC, Matthew DJ. Rehabilitation concepts in motor neuron diseases.
In: Braddom RL, ed. Physical Medicine & Rehabilitation, Ed. 1. Philadelphia,
WB Saunders. 1996;955-971.
|
|